Project Grant K08DA065752
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $7.09 million to the University of California, Los Angeles under the Drug Use and Addiction Research Programs (CFDA 93.279) for a four-year Avenir Award project running from July 1, 2025 through June 30, 2029. This research initiative addresses the critical gap between scientific evidence and policy implementation in substance use disorder (SUD) and HIV prevention services. The project aims to develop...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded $399,600 through its Drug Use and Addiction Research Programs (CFDA 93.279) to support a Mentored Research Scientist Development Award (K01) focused on developing dynamic treatment regimes for personalized opioid use disorder care. Awarded on August 15, 2025, with a completion date of July 31, 2030, this five-year career development and research initiative is led by Dr. Jason Brian Gibbons at the University of Colorado...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of California, San Diego $2,312,059 under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 1, 2025, for a five-year project period extending through April 30, 2030. The grant supports "Breaking Barriers: Innovating HIV Elimination with Social Network Strategies and Routine Substance Use Screening," a hybrid Type I clinical trial designed to identify and engage...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded University of Colorado-Denver a Project Grant of $709,085 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct an implementation trial examining in-hospital opioid treatment program (OTP) intake facilitation. The project, awarded April 1, 2026 with a completion date of January 31, 2031, will implement a series of evidence-based implementation facilitation activities across four hospitals to...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UC San Diego a Project Grant totaling $439,500 under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning March 1, 2026, with completion targeted for February 29, 2028. This grant supports the development of a novel research paradigm for collecting real-time, intensive longitudinal data on family dynamics and their relationship to adolescent substance use. The primary deliverable involves establishing...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Central Florida Board of Trustees a $1.59 million Project Grant on August 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to evaluate state policies facilitating emergency department-based treatment initiation for opioid use disorder (OUD). The project extends through May 31, 2030, and delivers two primary products: (1) creation of the first publicly available,...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UC San Diego a $1,118,834 Project Grant on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and implement an innovative community-informed modeling framework addressing HIV and Hepatitis C Virus (HCV) prevention resource allocation for people who use drugs (PWUD). The project will deliver a novel integrated system comprising: (1) artificially intelligent...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $493,444 to Lawrence Berkeley National Laboratory under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning March 15, 2026, with completion targeted for December 31, 2028. This project grant supports fundamental neuroscience research investigating the control principles underlying neural population dynamics, specifically examining how feedback control mechanisms shape brain activity and...
- Federal Project Grant Award Summary Award Details: The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a K23 career development grant to Dr. Shastry at Icahn School of Medicine at Mount Sinai for $195,228 (May 1, 2026 – April 30, 2031). This award supports the development and evaluation of a post-emergency department (ED) buprenorphine initiation support intervention targeting opioid use disorder (OUD) treatment adherence and...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,640 Project Grant to Massachusetts General Hospital (MGH), effective March 1, 2026 through February 28, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This four-year research initiative will deliver clinical outcomes research and health economic analysis focused on integrating infectious disease (ID) care into rapid-access substance use disorder (SUD) bridge clinics. The project...
The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $169,776 to the University of California, Los Angeles on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). This five-year research initiative, directed by Dr. Annette Dekker and extending through April 30, 2031, delivers a comprehensive health services research study examining the impact of California's Bridge Initiative policy on emergency department (ED)-initiated buprenorphine treatment for individuals with opioid use disorder. The research will produce causal inference analyses utilizing linked state-level administrative claims data, prescription drug monitoring program records, and mortality data to evaluate the ED-BUP Cascade—the continuum from ED-initiated buprenorphine prescription through linkage to care to continuous treatment. The project generates three primary research products: (1) a staggered difference-in-difference analysis quantifying the effect of CA Bridge implementation on ED-initiated buprenorphine treatment initiation and cascading care; (2) a retrospective cohort study assessing the relationship between the ED-BUP Cascade and mortality outcomes; and (3) a stratified analysis examining how treatment outcomes and policy impacts vary by urbanicity across California. Beyond research deliverables, the award supports career development training for Dr. Dekker in advanced addiction health services research methodologies and causal inference analysis, positioning her as an independent physician-scientist. Findings are designed to inform state and national policy interventions addressing opioid use disorder morbidity and mortality.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $169.8k | 5/7/26 |